REGMF
Price:
$12.05
Market Cap:
$63.35B
RemeGen Co., Ltd., a biopharmaceutical firm established in Yantai, People's Republic of China, in 2008, focuses on the discovery, development, and commercialization of biologics. The company aims to address unmet medical needs in autoimmune, oncology, and ophthalmic diseases across Mainland China and the United States. Its commercial portfolio includes Telitacicept (RC18), indicated for the autoimmune condition systemic lupus erythematosus, and Disitamab Vedotin (RC48), prescribed for various forms of cancer. RemeGen boasts a robust development pipeline. Telitacicept (RC18) is currently in Phase III clinical trials for neuromyelitis optica spectrum disorder and rheumatoid arthritis, and in P...[Read more]
Industry
Biotechnology
IPO Date
2021-01-21
Stock Exchange
OTC
Ticker
REGMF
According to RemeGen Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.58. This represents a change of 25.78% compared to the average of 1.26 of the last 4 quarters.
The mean historical Current Ratio of RemeGen Co., Ltd. over the last ten years is 2.36. The current 1.58 Current Ratio has changed 6.60% with respect to the historical average. Over the past ten years (40 quarters), REGMF's Current Ratio was at its highest in in the March 2022 quarter at 7.48. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
2.36
Median
1.69
Minimum
0.07
Maximum
6.90
Discovering the peaks and valleys of RemeGen Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.20%
Maximum Annual Current Ratio = 6.90
Minimum Annual Increase = -46.59%
Minimum Annual Current Ratio = 0.07
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.43 | 36.51% |
| 2024 | 1.05 | -46.59% |
| 2023 | 1.96 | -45.57% |
| 2022 | 3.60 | -3.52% |
| 2021 | 3.73 | -45.95% |
| 2020 | 6.90 | 4.20% |
| 2019 | 0.16 | 146.67% |
The current Current Ratio of RemeGen Co., Ltd. (REGMF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.48
5-year avg
2.35
10-year avg
2.36
RemeGen Co., Ltd.’s Current Ratio is less than Abivax S.A. (8.75), less than 3SBio Inc. (5.13), less than Shanghai Junshi Biosciences Co., Ltd. (2.14), less than Zealand Pharma A/S (37.17), greater than Sinopharm Group Co. Ltd. (1.41), less than Kyowa Kirin Co., Ltd. (3.18), greater than Genscript Biotech Corporation (1.47), greater than Ypsomed Holding AG (1.07), less than MatsukiyoCocokara & Co. (2.21), greater than Sinopharm Group Co. Ltd. (1.41),
| Company | Current Ratio | Market cap |
|---|---|---|
| 8.75 | $8.08B | |
| 5.13 | $5.50B | |
| 2.14 | $4.84B | |
| 37.17 | $3.16B | |
| 1.41 | $6.73B | |
| 3.18 | $7.55B | |
| 1.47 | $3.50B | |
| 1.07 | $4.67B | |
| 2.21 | $5.74B | |
| 1.41 | $7.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RemeGen Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is RemeGen Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for RemeGen Co., Ltd. (REGMF)?
What is the highest Current Ratio for RemeGen Co., Ltd. (REGMF)?
What is the 3-year average Current Ratio for RemeGen Co., Ltd. (REGMF)?
What is the 5-year average Current Ratio for RemeGen Co., Ltd. (REGMF)?
How does the current Current Ratio for RemeGen Co., Ltd. (REGMF) compare to its historical average?